Imago Rehab

TOMORROW: Don’t Miss Our Fireside Chat with Pirouette Medical & Safar Partners! 🎙️ Join us as our CEO, Chris Dugan, and CCO, Kristin Nuckols, dive into how we’re leveraging #AI and #robotics, to provide patients with comprehensive in-home therapy, addressing challenges in the $210B neurological and cardiovascular rehab market for the millions of Americans facing lasting motor impairment. We’ll be joined by Pirouette Medical, who is set to reshape the $750B injectable drug industry with their patented auto-injector, which is easy, safe, and accessible. 📅 When: Tomorrow! ⏰ Time: 9am PT/12pm ET There’s still time to secure your spot—sign up now! (link in comments) #MedTech #FiresideChat #ImagoRehab #TeleRehab #Innovation

We’re excited to announce that our investment round is gaining incredible momentum! In partnership with one of our institutional investors, Safar Partners, we’re hosting a special event you won’t want to miss. At Imago Rehab, we’re revolutionizing rehabilitation through our clinician-led telerehab platform, which harnesses the power of #AI and #robotics. Our solution provides comprehensive in-home therapy, tackling challenges in the $210 billion neurological and cardiovascular rehab market. Join our Co-Founder & CCO, Kristin Nuckols, and CEO, Chris Dugan, as they share the stage with Pirouette Medical and its CEO, Conor Cullinane, PhD. Together, we’ll discuss the future of rehabilitation and answer your questions LIVE! 💬 📅 Date: Friday, November 1st ⏰ Time: 9 AM PT / 12 PM ET 💻 Where: Registration link in the comments Don’t miss this opportunity to engage with industry leaders and gain insights into the future of health tech! #StrokeRecovery #HealthTech #FiresideChat #ImagoRehab #Fundraising #InvestmentOpportunity #TeleRehab #Innovation

Imago Rehab is excited to share that we were just recognized with an MDRN Leaders Award for our dedication to innovation in stroke and cardiovascular recovery. This award recognizes the significant impact of our AI-driven, clinician-led platform and wearable robotics. Imago was founded through breakthrough work at Harvard University, and our impact on those recovering from neurological and cardiovascular conditions is significant. We have already conducted over 3,500 therapy sessions, partnered with 23 insurers, and expanded to 8 states. While these accomplishments are impressive for a startup, we also believe we could do so much more. Like many early-stage companies, access to growth capital is one of the biggest obstacles to realizing our full potential. For that reason, we have decided to invite individuals to join us on this mission to expand our impact even further. Through our WeFunder campaign, individuals can invest in Imago Rehab and help shape the future of rehabilitation: wefunder.com/imago. We are grateful to everyone, from our existing institutional investors to friends and family, who has supported us on this journey. We are committed to leading the healthcare industry in driving change through AI innovation and are excited about the future. Invest today: wefunder.com/imago

We’re thrilled to announce that we’ve just launched our private community investment round on Wefunder. This exclusive opportunity allows our closest supporters to invest in our mission to revolutionize neurological and cardiovascular recovery before we open to the public. Imago Rehab is transforming the rehabilitation landscape with our AI-driven, clinician-led platform and innovative wearable robotics. Here’s what we’ve been up to: 1️⃣ Backed by AARP and venture capital firms including Safar Partners 2️⃣ Covered by 23 insurers across 8 states, with plans to expand to 14 states 3️⃣ Led by experts from Harvard, Aetna, Intel, Humana, and Hinge Health 4️⃣ Nearly $5M in non-dilutive R&D funding secured 5️⃣ Delivering 5x better outcomes than traditional therapy As a member of our community, you’re getting exclusive early access with special terms. Invest now and join us in making a real difference—before this opportunity goes public! This is just the beginning. You can join us in making rehabilitation more accessible by investing (from $100 to $500K+) at wefunder.com/imago. If you have any questions, we’d love to hear from you—drop them below!

Thanks to AARP and the AgeTech Collaborative™ from AARP for the continued support! #healthcareinnovation

We are thrilled to share that earlier today, the National Board for Certification in Occupational Therapy (NBCOT) recognized our co-founder and Chief Clinical Officer, Kristin Nuckols with their 2024 Innovation Award. You can read the press release here: https://lnkd.in/ghjNcBja #stroke #healthcareinnovation #occupationaltherapy #startup #seedfunding

Imago Rehab is very excited to announce the launch of our redesigned website (www.imagorehab.com). As an innovative new health tech business that was launched out of Harvard University in 2021, our vision is to bring together soft robotic technology, asynchronous patient monitoring and behavioral prompts, and one-on-one occupational/physical/speech therapy to make high-quality therapy available to those recovering from neurologic and cardiovascular conditions wherever they may be. With this new website, we’ve made the Imago story far more accessible to patients, providers, partners, and investors, and we know it will play a key role as we pursue our growth agenda. Thanks to our partners Mend - A growth advisory firm and Lisa Baggerman Hazen for helping us tell our story.